Literature DB >> 17095176

[Contribution of microbiological investigations to the diagnosis of lower respiratory tract infections].

O Leroy1.   

Abstract

The diagnosis of community-acquired pneumonia is usually based on clinical and radiological criteria. The identification of a causative organism is not required for the diagnosis. Although numerous microbiological techniques are available, their sensitivity and specificity are not high enough to guide first-line antimicrobial therapy. Consequently, this treatment remains most often empiric. If the causative organism is identified, the antimicrobial treatment is adapted. Sputum analysis may be proposed as a diagnostic tool for patients with an acute exacerbation of chronic obstructive pulmonary disease, in specific cases (prior antibiotherapy, hospitalization, failure of the empiric antimicrobial treatment).

Entities:  

Mesh:

Year:  2006        PMID: 17095176      PMCID: PMC7119138          DOI: 10.1016/j.medmal.2006.07.008

Source DB:  PubMed          Journal:  Med Mal Infect        ISSN: 0399-077X            Impact factor:   2.152


  169 in total

1.  BTS Guidelines for the Management of Community Acquired Pneumonia in Adults.

Authors: 
Journal:  Thorax       Date:  2001-12       Impact factor: 9.139

Review 2.  Chips with everything: DNA microarrays in infectious diseases.

Authors:  Penelope A Bryant; Deon Venter; Roy Robins-Browne; Nigel Curtis
Journal:  Lancet Infect Dis       Date:  2004-02       Impact factor: 25.071

3.  Evaluation of a direct immunofluorescence assay, dot-blot enzyme immunoassay, and shell vial culture in the diagnosis of lower respiratory tract infections caused by influenza A virus.

Authors:  J Reina; M Munar; I Blanco
Journal:  Diagn Microbiol Infect Dis       Date:  1996-07       Impact factor: 2.803

4.  Sputum gram's stain in community-acquired pneumococcal pneumonia. A meta-analysis.

Authors:  W W Reed; G S Byrd; R H Gates; R S Howard; M J Weaver
Journal:  West J Med       Date:  1996-10

5.  Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity.

Authors:  M Ruiz; S Ewig; M A Marcos; J A Martinez; F Arancibia; J Mensa; A Torres
Journal:  Am J Respir Crit Care Med       Date:  1999-08       Impact factor: 21.405

6.  Community-acquired pneumonia in the intensive care unit: epidemiological and prognosis data in older people.

Authors:  O Leroy; C Bosquet; C Vandenbussche; C Coffinier; H Georges; B Guery; S Alfandari; D Thevenin; G Beaucaire
Journal:  J Am Geriatr Soc       Date:  1999-05       Impact factor: 5.562

7.  Usefulness of PCR and antigen latex agglutination test with samples obtained by transthoracic needle aspiration for diagnosis of pneumococcal pneumonia.

Authors:  A García; B Rosón; J L Pérez; R Verdaguer; J Dorca; J Carratalà; A Casanova; F Manresa; F Gudiol
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

8.  Comparative study of community-acquired pneumonia caused by Streptococcus pneumoniae, Legionella pneumophila or Chlamydia pneumoniae.

Authors:  Nieves Sopena; Maria Luisa Pedro-Botet; Miquel Sabrià; Delia García-Parés; Esteban Reynaga; Marian García-Nuñez
Journal:  Scand J Infect Dis       Date:  2004

Review 9.  Pneumonia in older persons.

Authors:  Mark Loeb
Journal:  Clin Infect Dis       Date:  2003-10-13       Impact factor: 9.079

10.  A five-year study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an intensive care unit.

Authors:  O Leroy; C Santré; C Beuscart; H Georges; B Guery; J M Jacquier; G Beaucaire
Journal:  Intensive Care Med       Date:  1995-01       Impact factor: 17.440

View more
  1 in total

Review 1.  [Description and role of bacteriological techniques in the management of lung infections].

Authors:  S Dahyot; L Lemee; M Pestel-Caron
Journal:  Rev Mal Respir       Date:  2017-07-05       Impact factor: 0.622

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.